Antenatal corticosteroid therapy and COVID-19: Pathophysiological considerations

Acta Obstet Gynecol Scand. 2020 Jul;99(7):952. doi: 10.1111/aogs.13887. Epub 2020 May 17.

Authors

Joanna Sichitiu¹, Fadi Fakhouri², David Desseauve¹

Affiliations

¹ Women-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.
² Department of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland.

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus / physiology
COVID-19
Coronavirus Infections* / drug therapy
Coronavirus Infections* / metabolism
Female
Fetal Organ Maturity / drug effects*
Glucocorticoids* / administration & dosage
Glucocorticoids* / adverse effects
Humans
Pandemics*
Pneumonia, Viral* / drug therapy
Pneumonia, Viral* / metabolism
Pregnancy
Pregnancy Complications, Infectious* / drug therapy
Pregnancy Complications, Infectious* / metabolism
Prenatal Care / methods*
Renin-Angiotensin System / drug effects*
Risk Assessment
SARS-CoV-2

Substances

Glucocorticoids